VBI Vaccines Inc (NASDAQ:VBIV)
| 0.8563 Delayed Data As of May 25 |  +0.0126 / +1.49%Today’s Change | 0.83 Today|||52-Week Range 4.31 | -63.41% Year-to-Date |
Latest VBIV News | Press Releases
No recent news for VBI Vaccines Inc.
Today’s Trading
| Previous close | 0.84 |
| Today’s open | 0.84 |
| Day’s range | 0.83 - 0.89 |
| Volume | 1,417,490 |
| Average volume (3 months) | 2,184,699 |
| Market cap | $256.6M |
Data as of 3:59pm ET, 05/25/2022
Growth & Valuation
| Earnings growth (last year) | -29.18% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -40.53% |
| P/E ratio | NM |
| Price/Sales | 945.45 |
| Price/Book | 1.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| COGTCogent Biosciences I... | +0.12 | +2.59% |
| BLUEbluebird bio Inc | +0.06 | +2.04% |
| VYGRVoyager Therapeutics... | -0.09 | -1.49% |
| VSTMVerastem Inc | -0.01 | -0.80% |
Data as of 4:00pm ET, 05/25/2022
Financials
| Next reporting date | August 1, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $631.0K |
| Annual profit (last year) | -$69.8M |
| Net profit margin | -11,054.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
